Clinical Trial Update: Phase 1 LEISH-F3 Vaccine Trial in Healthy Adult Volunteers [Phase 1]

View source ↗

Summary

Phase 1 assessment of the LEISH-F3 vaccine in healthy adult volunteers has been completed, reporting safety and immunogenicity data for leishmaniasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Leishmaniasis

Drugs mentioned

• LEISH-F3 vaccine (LEISH-F3)

Snippet

Sponsor: Access to Advanced Health Institute (AAHI) | Conditions: Leishmaniasis | Phase 1 | Status: COMPLETED